UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035898
Receipt number R000040740
Scientific Title Effects of Smartphone Application-Based Integrated Self-Care Support System for Hypertensive Patients
Date of disclosure of the study information 2019/02/18
Last modified on 2023/05/13 22:09:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of Smartphone Application-Based
Integrated Self-Care Support System
for Hypertensive Patients

Acronym

AppCare-HT Study

Scientific Title

Effects of Smartphone Application-Based
Integrated Self-Care Support System
for Hypertensive Patients

Scientific Title:Acronym

AppCare-HT Study

Region

Japan


Condition

Condition

Hypertension

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether smartphone application-based integrated self-care support system may reduce blood pressure in hypertensive patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in systolic blood pressure from baseline to 12 months

Key secondary outcomes

1.Change in systolic blood pressure from baseline to 6 months
2.Change in diastolic blood pressure from baseline to each follow-up point (6 months and 12 months)
3.Change in frequency of blood pressure measurements at home from baseline to each follow-up point (6 months and 12 months)
4.Systolic blood pressure
5.Diastolic blood pressure
6.Frequency of blood pressure measurements at home
7.Quality of life (EQ-5D-5L)
8.Self-efficacy (GSES)
9.Medication-taking adherence (MMAS-4)
10.Medical cost
11.Adverse events
12.Change in number or dosage of antihypertensive medicine
13.Days until change of antihypertensive medicine after the start of clinical study
14.Self-monitoring data
15.Frequency of use of smartphone application


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Application group

Interventions/Control_2

Non-application group (control group)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Hypertensive patients whose blood pressure at the clinic or physical check-up is more than 140/90mmHg irrespective of taking antihypertensive agents

Key exclusion criteria

1.A patient who cannot use smartphone application
2.A patient diagonized as secondary hypertension
3.A patient with chronic atrial fibrillation
4.A patient with severe renal failure (eGFR<15mL/min/1.73m2) or a dialysis patient
5.A patient who has a history of major cardiovascular events within the past 3 months
6.A patient whose antihypertensive medication was changed within the past 1 month
7.A patient who has a plan of hospitalization due to surgery or examination at the time of study participation
8.A patient who is using another smartphone application for hypertension at the time of study participation
9.A patients who is judged as inappropriate for the study participation by the principal investigator

Target sample size

360


Research contact person

Name of lead principal investigator

1st name Toshihisa
Middle name
Last name Anzai

Organization

Hokkaido University

Division name

Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine

Zip code

060-8638

Address

Kita-15 Nishi-7, Kita-Ku, Sapporo, Japan

TEL

011-706-6973

Email

anzai@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Yokota

Organization

Hokkaido University

Division name

Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine

Zip code

060-8638

Address

Kita-15 Nishi-7, Kita-Ku, Sapporo, Japan

TEL

011-706-6973

Homepage URL


Email

t-yokota@med.hokudai.ac.jp


Sponsor or person

Institute

Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)

Japan Science and Technology Agency


IRB Contact (For public release)

Organization

Hokkaido University Hospital Certified Review Board

Address

Kita-14 Nishi-5, Kita-Ku, Sapporo 060-8648, Japan

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

360

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 01 Month 29 Day

Date of IRB

2019 Year 02 Month 19 Day

Anticipated trial start date

2019 Year 02 Month 26 Day

Last follow-up date

2023 Year 03 Month 25 Day

Date of closure to data entry

2023 Year 03 Month 25 Day

Date trial data considered complete

2023 Year 04 Month 30 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 02 Month 17 Day

Last modified on

2023 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040740


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name